IGM Biosciences Inc.

1.16
-0.08 (-6.45%)
At close: Mar 31, 2025, 3:59 PM
1.15
-0.36%
After-hours: Mar 31, 2025, 05:34 PM EDT

IGM Biosciences Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -195.79M -246.42M -221.1M -165.16M -81.36M -43.13M -22.71M -11.05M
Depreciation & Amortization 9.11M 8.28M 6.08M 4.48M 1.02M 597K 278K 161K
Stock-Based Compensation 38.27M 46.55M 44.71M 25.87M 8.45M 1.01M 183K 93K
Other Working Capital -6.8M -5.7M 158.17M 5.79M -153K -6.99M 2.24M 315K
Other Non-Cash Items 2.53M 6.05M 9.29M 3.24M 2.55M 1.74M 27K 287K
Deferred Income Tax n/a n/a n/a 781K -23K -306K n/a n/a
Change in Working Capital -7.11M -6.69M 155.17M 6.45M 2.04M -5.02M 2.18M 443K
Operating Cash Flow -153M -192.23M -5.85M -124.34M -67.3M -45.12M -20.04M -10.36M
Capital Expenditures -5.85M -12.38M -10.21M -13.24M -17.5M -2.34M -788K -385K
Acquisitions n/a n/a 7.37M -28.7M -57.71M 200.9M n/a n/a
Purchase of Investments -215.39M -365.04M -540.02M -129.35M -208.56M -208.9M n/a n/a
Sales Maturities Of Investments 289.4M 445.77M 324.58M 157.41M 283.78M 8M n/a n/a
Other Investing Acitivies -4M n/a -7.37M 28.7M 57.71M -200.9M n/a n/a
Investing Cash Flow 64.16M 68.36M -225.64M 14.82M 57.71M -203.24M -788K -385K
Debt Repayment n/a n/a n/a n/a n/a 15M 5M n/a
Common Stock Repurchased n/a n/a n/a -1.55M n/a -324K n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 2.39M 3.01M 1.4M 2.48M -910K 348.93M 34.67M 8.07M
Financial Cash Flow 2.39M 115.07M 219.38M 2.48M 214.78M 282.26M 22.34M 8.07M
Net Cash Flow -86.45M -8.81M -12.12M -107.05M 205.19M 33.9M 1.5M -2.67M
Free Cash Flow -158.85M -204.61M -16.06M -137.58M -84.81M -47.45M -20.83M -10.74M